BIOMARKER IDENTIFYING THE REACTIVATION OF STAT3 AFTER SRC INHIBITION

摘要

A method of identifying cancer or an associated disorder comprising identifying and quantifying STAT3 occurring in a biological sample taken from a subject after administering a SFK inhibitor to said subject.